These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Intracavernous auto-injection of prostaglandin E1 for diagnosis and treatment of erectile dysfunction]. Arielly J; Weinberg D; Eliraz A; Adam M; el-Hanani BI; Eisenkraft S Harefuah; 1994 Apr; 126(7):369-73, 426. PubMed ID: 8200581 [TBL] [Abstract][Full Text] [Related]
5. Use of intracavernous injection of prostaglandin E1 for neuropathic erectile dysfunction. Hirsch IH; Smith RL; Chancellor MB; Bagley DH; Carsello J; Staas WE Paraplegia; 1994 Oct; 32(10):661-4. PubMed ID: 7831071 [TBL] [Abstract][Full Text] [Related]
6. The role of intracavernosal vasoactive agents to overcome impotence due to spinal cord injury. Earle CM; Keogh EJ; Ker JK; Cherry DJ; Tulloch AG; Lord DJ Paraplegia; 1992 Apr; 30(4):273-6. PubMed ID: 1625897 [TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E1 with phentolamine for the treatment of erectile dysfunction. Meinhardt W; de la Fuente RB; Lycklama à Nijeholt AA; Vermeij P; Zwartendijk J Int J Impot Res; 1996 Mar; 8(1):5-7. PubMed ID: 8735187 [TBL] [Abstract][Full Text] [Related]
8. [Dose adaptation during training of intracavernous self-injections of prostaglandin E1]. Staerman F; Veilhan LA; Guiraud P; Coeurdacier P; Cipolla B; Lobel B Prog Urol; 1996; 6(4):564-8. PubMed ID: 8924934 [TBL] [Abstract][Full Text] [Related]
9. [Intracavernous injection of vasoactive drugs for treating erectile impotence]. Yasumoto R; Asakawa M; Kawashima H; Yoshimura R; Maekawa T; Kashiwara N; Tanaka H; Nishio S Hinyokika Kiyo; 1988 Feb; 34(2):301-4. PubMed ID: 2454019 [TBL] [Abstract][Full Text] [Related]
16. [Initial experiences with prostaglandin E1 and PGE1 prepared injections]. Mattarelli G; Leibundgut B Helv Chir Acta; 1991 Sep; 58(3):335-7. PubMed ID: 1769856 [TBL] [Abstract][Full Text] [Related]
17. Penile scarring with intracavernous injection therapy using prostaglandin E1: a risk factor analysis. Chen RN; Lakin MM; Montague DK; Ausmundson S J Urol; 1996 Jan; 155(1):138-40. PubMed ID: 7490812 [TBL] [Abstract][Full Text] [Related]
18. [Intracavernous injection of papaverine hydrochloride for impotence in patients with spinal cord injury]. Momose H; Natsume O; Yamamoto M; Suemori T; Yamada K Hinyokika Kiyo; 1987 Jul; 33(7):1065-9. PubMed ID: 3687629 [TBL] [Abstract][Full Text] [Related]
19. Intracavernous injections for erectile dysfunction in patients with cardiovascular diseases and failure or contraindications for sildenafil citrate. Israilov S; Niv E; Livne PM; Shmueli J; Engelstein D; Segenreich E; Baniel J Int J Impot Res; 2002 Feb; 14(1):38-43. PubMed ID: 11896476 [TBL] [Abstract][Full Text] [Related]
20. [The therapeutic and diagnostic potentials of the intra-corpora cavernosa use of alprostadil, Edex, in patients with erectile dysfunction]. Mzo EB; Dmitriev DG Ter Arkh; 1995; 67(10):45-8. PubMed ID: 8779105 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]